Moreover, the inhibition of VCAN amplifies the anti-tumour effectiveness of endostatin by mitigating the induced accumulation of myeloid-derived suppressor cells (MDSCs), tumour-associated macrophages (TAMs), and inflammatory cytokines within the TME [270]. The gene discussed is COL18A1; the disease is neoplasm.